heparin: be contraindicated in endocarditis

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.72
, blood
Weight: 0.57
, agent
Weight: 0.56
, molecule
Weight: 0.56
Siblings acetaminophen
Weight: 0.37
, fentanyl
Weight: 0.37
, warfarin
Weight: 0.36
, vancomycin
Weight: 0.36

Related properties

Property Similarity
be contraindicated in endocarditis 1.00
be contraindicated in hypertension 0.90
contraindicated in subarachnoid hemorrhage 0.89
induced thrombocytopenia cause thrombosis 0.79
be used for myocardial infarction 0.76
be used for infarction 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.45
Similarity weight: 1.00
Evidence: 0.73
¬ Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.76
¬ Remarkable(warfarin, be contraindicated in endocarditis)
0.06
Rule weight: 0.13
Evidence weight: 0.47
Similarity weight: 0.90
Evidence: 0.73
¬ Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.73
¬ Remarkable(warfarin, be contraindicated in hypertension)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.76
Remarkable(warfarin, be contraindicated in endocarditis) ⋁
Evidence: 0.82
¬ Plausible(warfarin, be contraindicated in endocarditis)
0.51
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.90
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.73
Remarkable(warfarin, be contraindicated in hypertension) ⋁
Evidence: 0.85
¬ Plausible(warfarin, be contraindicated in hypertension)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.89
¬ Salient(heparin, be contraindicated in endocarditis)

Similarity expansion

0.69
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.90
Evidence: 0.89
Salient(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.90
¬ Salient(heparin, be contraindicated in hypertension)
0.68
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.89
Evidence: 0.89
Salient(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.88
¬ Salient(heparin, contraindicated in subarachnoid hemorrhage)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.78
Typical(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.79
¬ Typical(heparin, be contraindicated in hypertension)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.78
¬ Plausible(heparin, be contraindicated in hypertension)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.89
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.79
¬ Plausible(heparin, contraindicated in subarachnoid hemorrhage)
0.62
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.89
Evidence: 0.78
Typical(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.81
¬ Typical(heparin, contraindicated in subarachnoid hemorrhage)
0.61
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.89
Evidence: 0.73
Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.69
¬ Remarkable(heparin, contraindicated in subarachnoid hemorrhage)
0.61
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.90
Evidence: 0.73
Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.79
Evidence: 0.89
Salient(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.93
¬ Salient(heparin, induced thrombocytopenia cause thrombosis)
0.59
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.76
Evidence: 0.89
Salient(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.74
¬ Salient(heparin, be used for infarction)
0.58
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.76
Evidence: 0.89
Salient(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.85
¬ Salient(heparin, be used for myocardial infarction)
0.56
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.78
Typical(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.62
¬ Typical(heparin, be used for infarction)
0.56
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.76
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.63
¬ Plausible(heparin, be used for infarction)
0.55
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.79
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.84
¬ Plausible(heparin, induced thrombocytopenia cause thrombosis)
0.55
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.79
Evidence: 0.78
Typical(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.86
¬ Typical(heparin, induced thrombocytopenia cause thrombosis)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.73
Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.71
¬ Remarkable(heparin, induced thrombocytopenia cause thrombosis)
0.54
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.76
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.77
¬ Plausible(heparin, be used for myocardial infarction)
0.53
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.76
Evidence: 0.78
Typical(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.81
¬ Typical(heparin, be used for myocardial infarction)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.73
Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.65
¬ Remarkable(heparin, be used for myocardial infarction)
0.52
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.76
Evidence: 0.73
Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.71
¬ Remarkable(heparin, be used for infarction)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.89
Salient(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.78
¬ Typical(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.73
¬ Remarkable(heparin, be contraindicated in endocarditis)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.78
Plausible(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.78
¬ Typical(heparin, be contraindicated in endocarditis)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.41
Similarity weight: 1.00
Evidence: 0.73
¬ Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.82
¬ Typical(warfarin, be contraindicated in endocarditis)
0.04
Rule weight: 0.14
Evidence weight: 0.37
Similarity weight: 0.90
Evidence: 0.73
¬ Remarkable(heparin, be contraindicated in endocarditis) ⋁
Evidence: 0.87
¬ Typical(warfarin, be contraindicated in hypertension)